blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3577219

EP3577219 - ALPHA-AMYLASE VARIANTS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  27.06.2024
Database last updated on 12.12.2024
FormerThe patent has been granted
Status updated on  21.07.2023
FormerGrant of patent is intended
Status updated on  16.03.2023
FormerExamination is in progress
Status updated on  22.10.2020
FormerRequest for examination was made
Status updated on  08.11.2019
FormerThe international publication has been made
Status updated on  11.08.2018
Formerunknown
Status updated on  16.03.2018
Most recent event   Tooltip15.11.2024Lapse of the patent in a contracting state
New state(s): BG		published on 18.12.2024 [2024/51]
Applicant(s)For all designated states
Novozymes A/S
Krogshoejvej 36
2880 Bagsvaerd / DK
[2019/50]
Inventor(s)01 / ANDERSEN, Carsten
Krogshoejvej 36
2880 Bagsvaerd / DK
02 / DAMAGER, Iben
Krogshoejvej 36
2880 Bagsvaerd / DK
03 / GHADIYARAM, Chakshusmathi
Plot No. 32
47-50 EPIP Area
Whitefield
Bangalore 560 066 / IN
04 / SAINATHAN, Rajendra, Kulothungan
Plot No. 32
47-50 EPIP Area
Whitefield
Bangalore 560 066 / IN
05 / IYER, Padma, Venkatachalam
Plot No. 32
47-50 EPIP Area
Whitefield
Bangalore 560 066 / IN
 [2019/50]
Representative(s)NZ EPO Representatives
Krogshoejvej 36
2880 Bagsvaerd / DK
[2019/50]
Application number, filing date18708589.930.01.2018
[2019/50]
WO2018EP52197
Priority number, dateIN20174100368601.02.2017         Original published format: IN201741003686
EP2017016311427.03.2017         Original published format: EP 17163114
[2019/50]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2018141707
Date:09.08.2018
Language:EN
[2018/32]
Type: A2 Application without search report 
No.:EP3577219
Date:11.12.2019
Language:EN
The application published by WIPO in one of the EPO official languages on 09.08.2018 takes the place of the publication of the European patent application.
[2019/50]
Type: B1 Patent specification 
No.:EP3577219
Date:23.08.2023
Language:EN
[2023/34]
Search report(s)International search report - published on:EP07.02.2019
ClassificationIPC:C12N9/26
[2019/50]
CPC:
C12N9/2414 (EP); C12N9/2417 (US); C12N15/63 (US);
C12Y302/01001 (US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/50]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:ALPHA-AMYLASE VARIANTEN[2023/09]
English:ALPHA-AMYLASE VARIANTS[2019/50]
French:VARIANTS D'ALPHA-AMYLASES[2019/50]
Former [2019/50]ALPHA-AMYLASE-VARIANTEN
Entry into regional phase02.09.2019National basic fee paid 
02.09.2019Designation fee(s) paid 
02.09.2019Examination fee paid 
Examination procedure02.09.2019Examination requested  [2019/50]
02.09.2019Date on which the examining division has become responsible
12.03.2020Amendment by applicant (claims and/or description)
21.10.2020Despatch of a communication from the examining division (Time limit: M04)
26.02.2021Reply to a communication from the examining division
06.07.2021Despatch of a communication from the examining division (Time limit: M04)
04.11.2021Reply to a communication from the examining division
17.03.2023Communication of intention to grant the patent
11.07.2023Fee for grant paid
11.07.2023Fee for publishing/printing paid
11.07.2023Receipt of the translation of the claim(s)
Divisional application(s)EP23189225.8  / EP4276179
Opposition(s)24.05.2024No opposition filed within time limit [2024/31]
Fees paidRenewal fee
31.01.2020Renewal fee patent year 03
01.02.2021Renewal fee patent year 04
31.01.2022Renewal fee patent year 05
31.01.2023Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipBG23.08.2023
CZ23.08.2023
EE23.08.2023
FI23.08.2023
HR23.08.2023
LT23.08.2023
LV23.08.2023
MC23.08.2023
PL23.08.2023
RO23.08.2023
RS23.08.2023
SE23.08.2023
SI23.08.2023
SK23.08.2023
SM23.08.2023
NO23.11.2023
GR24.11.2023
IS23.12.2023
PT26.12.2023
LU30.01.2024
CH31.01.2024
[2024/51]
Former [2024/48]CZ23.08.2023
EE23.08.2023
FI23.08.2023
HR23.08.2023
LT23.08.2023
LV23.08.2023
MC23.08.2023
PL23.08.2023
RO23.08.2023
RS23.08.2023
SE23.08.2023
SI23.08.2023
SK23.08.2023
SM23.08.2023
NO23.11.2023
GR24.11.2023
IS23.12.2023
PT26.12.2023
LU30.01.2024
CH31.01.2024
Former [2024/43]CZ23.08.2023
EE23.08.2023
FI23.08.2023
HR23.08.2023
LT23.08.2023
LV23.08.2023
MC23.08.2023
PL23.08.2023
RO23.08.2023
RS23.08.2023
SE23.08.2023
SI23.08.2023
SK23.08.2023
SM23.08.2023
NO23.11.2023
GR24.11.2023
IS23.12.2023
PT26.12.2023
LU30.01.2024
Former [2024/40]CZ23.08.2023
EE23.08.2023
FI23.08.2023
HR23.08.2023
LT23.08.2023
LV23.08.2023
MC23.08.2023
PL23.08.2023
RO23.08.2023
RS23.08.2023
SE23.08.2023
SI23.08.2023
SK23.08.2023
SM23.08.2023
NO23.11.2023
GR24.11.2023
IS23.12.2023
PT26.12.2023
Former [2024/36]CZ23.08.2023
EE23.08.2023
FI23.08.2023
HR23.08.2023
LT23.08.2023
LV23.08.2023
PL23.08.2023
RO23.08.2023
RS23.08.2023
SE23.08.2023
SI23.08.2023
SK23.08.2023
SM23.08.2023
NO23.11.2023
GR24.11.2023
IS23.12.2023
PT26.12.2023
Former [2024/23]CZ23.08.2023
EE23.08.2023
FI23.08.2023
HR23.08.2023
LT23.08.2023
LV23.08.2023
PL23.08.2023
RO23.08.2023
RS23.08.2023
SE23.08.2023
SK23.08.2023
SM23.08.2023
NO23.11.2023
GR24.11.2023
IS23.12.2023
PT26.12.2023
Former [2024/20]FI23.08.2023
HR23.08.2023
LT23.08.2023
LV23.08.2023
PL23.08.2023
RS23.08.2023
SE23.08.2023
SM23.08.2023
NO23.11.2023
GR24.11.2023
IS23.12.2023
PT26.12.2023
Former [2024/10]FI23.08.2023
HR23.08.2023
LT23.08.2023
LV23.08.2023
PL23.08.2023
RS23.08.2023
SE23.08.2023
NO23.11.2023
GR24.11.2023
IS23.12.2023
PT26.12.2023
Former [2024/09]FI23.08.2023
LT23.08.2023
SE23.08.2023
NO23.11.2023
GR24.11.2023
IS23.12.2023
Former [2024/08]LT23.08.2023
NO23.11.2023
GR24.11.2023
Cited inInternational search[XI]EP2540824  (PROCTER & GAMBLE [US]);
 [XI]WO2013001078  (NOVOZYMES AS [DK], et al);
 [XI]EP3121270  (PROCTER & GAMBLE [US])
by applicantEP0238023
 WO9206204
 US5223409
 WO9517413
 WO9522625
 WO9533836
 WO9600787
 WO9623873
 US6020303
 US6060443
 WO0056900
 WO0060060
 WO0242740
 US2004171154
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.